Epratuzumab (CD22) - Research Grade Biosimilar
Product Specifications
Background
Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2) .This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.
Swiss Prot
P20273
Immunogen
Humanized / CD22 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-nd
NCBI Organism
Homo sapiens
Other Product Names
90Y-DOTA-hLL2,90Y-epratuzumab tetraxetan, AMG-412,90Y-hLL2, hLL2, CD22, CD22
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
